Acute Congestive Heart Failure Urgent Care Evaluation

This prospective validation study evaluates the ability of a risk algorithm, which can simultaneously predict the risk of death at 7 days and 30 days for patients with acute heart failure presenting to the emergency department. The risk algorithms for prediction of 7-day (Emergency Heart failure Mortality Risk Grade [EHMRG]) and 30-day mortality (EHMRG30-ST) have been previously derived.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Health Network

Toronto, Ontario, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with acute heart failure diagnosed in the emergency department

Exclusion criteria

Palliative or do-not-resuscitate (DNR) directive
Dialysis dependent

Treatment and study plan

Primary outcomes

Mortality

Time frame: 7 days

Death within 7 days after emergency department presentation for heart failure
Mortality

Time frame: 30 days

Death within 30 days after emergency department presentation for heart failure

Sponsors and collaborators

Lead sponsor

Institute for Clinical Evaluative Sciences

Other

Registry information

Official study title

Acute Congestive Heart Failure Urgent Care Evaluation: Prospective Validation of the Emergency Heart Failure Mortality Risk Grade 7-day and 30-day Algorithms in the Emergency Department

Acronym: ACUTE

Important dates

Study start: 2011
Primary completion: 2017
Study completion: 2017
First posted: Dec 18, 2015
Registry last updated: Mar 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed